Nachrichten zur Amneal Pharmaceuticals Aktie

Amneal (AMRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal”) (Nasdaq: AMRX) announced that its subsidiary,…

…

Amneal (AMRX) delivered earnings and revenue surprises of 40% and 2.71%, respectively, for the quarter ended March 2025. Do the…

Amneal (AMRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

…

…

Amneal (AMRX) delivered earnings and revenue surprises of 14.29% and 6.75%, respectively, for the quarter ended June 2024. Do the…

…

The Global Muscle Relaxant Drugs Market Size was Valued at USD 3.90 Billion in 2023 and the Worldwide Muscle Relaxant…

The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription…

…

…

Amneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to resolve claims it…

Amneal (AMRX) delivered earnings and revenue surprises of 55.56% and 5.80%, respectively, for the quarter ended March 2024. Do the…

The Global Testosterone Replacement Therapy Market Size was Valued at USD 1.98 Billion in 2023 and the Worldwide Testosterone Replacement…

Bausch (BHC) initiates litigation against Amneal Pharmaceuticals and its subsidiaries over a generic version of its lead drug Xifaxan.…

The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…

Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023…

…

…

Amneal (AMRX) delivered earnings and revenue surprises of 100% and 2.17%, respectively, for the quarter ended December 2023. Do the…